Asnaghi, Laura <br/><br/>
Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt.  [electronic resource] 

 -  Oncogene  Jul 2004 
 - 5781-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1207698  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Cells, Cultured<br/>Dose-Response Relationship, Drug<br/>G2 Phase--drug effects<br/>Microtubules--drug effects<br/>Mitosis--drug effects<br/>Mutation<br/>Nocodazole--pharmacology<br/>Paclitaxel--pharmacology<br/>Phosphorylation<br/>Protein Kinases--metabolism<br/>Protein Serine-Threonine Kinases--genetics<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins c-akt<br/>Proto-Oncogene Proteins c-bcl-2--drug effects<br/>Ribosomal Protein S6 Kinases, 70-kDa--metabolism<br/>Serine--metabolism<br/>Signal Transduction<br/>Sirolimus--pharmacology<br/>TOR Serine-Threonine Kinases